Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
RM-1995 Photoimmunotherapy, as Monotherapy or Combined With Pembrolizumab, in Patients With Advanced CuSCC and HNSCC
- Status
- WITHDRAWN
- Phase
- PHASE1
RTX-224 Monotherapy in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?
- Status
- RECRUITING
- Phase
- N/A
The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC
- Status
- COMPLETED
- Phase
- PHASE2
The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Camrelizumab in Combination With Apatinib Mesylate Plus Albumin-bound Paclitaxel and Cisplatin as the First Line Treatment of Recurrent or Metastatic, UnresectableHead and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Comparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Correlation of Fecal Microbiome and Its Metabolites With Outcome of Radiotherapy in Head and Neck Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Acupuncture for Dysphagia in Head and Neck Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Liquid Biopsy of Head and Neck Cancer Patients in Blood and Saliva
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of NX-1607 in Adults With Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Sleep and Circadian Rhythm Study in Head and Neck Cancer Patients
- Status
- WITHDRAWN
- Phase
- NA
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2